Eurobio Scientific (ENXTPA: ALERS) enters into exclusive negotiations with In Veritas Medical Diagnostics, Inc. (OTCPK:IVME) for the acquisition of Pathway Diagnostics Ltd and Personal Diagnostics Incorporated (OTCPK:PERS). This acquisition should be made with a partial payment in cash, supplemented by an exchange of shares. The acquisition of both companies is expected to be paid in cash and an exchange of shares.

The latter would be made by issuing new shares for an amount of £900,000, and based on the weighted average price of the Eurobio Scientific shares calculated over the last 20 trading days preceding the annual general shareholders' meeting to be held on June 27, 2019.